Symbiomics completes Series A funding round led by Corteva to advance next-generation biologicals

Share This Article

Symbiomics, a leading-edge biotechnology company focused on high-performance biological solutions for agriculture, has announced the successful completion of its Series A funding round, led by Corteva Agriscience through its strategic investment platform, Corteva Catalyst. This marks Corteva’s first investment in Brazil via Catalyst and represents a major milestone in Symbiomics’ growth journey. The funding will enable the company to scale its operations, advance its proprietary microbial discovery platform, and fast-track the commercialization of novel biological products. With additional backing from investors including Arar Capital, Cazanga, MOV Investimentos, and The Yield Lab Latam, this round underscores the growing confidence in Symbiomics’ vision to deliver sustainable, next-generation solutions for global agriculture.

Read the Full Press Release below –

Symbiomics completes Series A funding round led by Corteva to advance next-generation biologicals

Corteva’s first investment in Brazil, the strategic funding leverages product launch and expands partnerships across the agricultural sector

June 25, 2025 (Florianópolis, SC, Brazil)
Symbiomics, a biotechnology company that develops high-performance biological products for agriculture, today announced the completion of its Series A funding round to scale its operations, accelerate the development of novel products, and expand its commercial partnerships. The round is led by Corteva Agriscience through its investment platform, Corteva Catalyst, launched in mid-2024. In addition to the multinational, the Series A round includes investments from Arar Capital, Cazanga, MOV Investimentos, and The Yield Lab Latam.

The Brazilian company is the first to receive an investment from Corteva Catalyst in the country. “Corteva’s investment represents an important recognition of Symbiomics as a company committed to developing innovative technologies for agribusiness,” said Rafael de Souza, co-founder and CEO of the company. “More than that, it is a significant step toward a more sustainable agriculture. The Series A funding will allow us to accelerate our developments and strengthen partnerships across the sector,” he added.

Symbiomics’ proprietary platform enables the analysis of thousands of microorganisms in search of the most robust strains, with greater efficiency and precision than traditional methodologies. It also incorporates gene editing and molecular discovery technologies, main drivers for the next generation of biological products. Targeting a biologicals market expected to reach US$ 3.1 billion by 2030, Corteva Catalyst is making its first investment in Brazil by backing Symbiomics’ ability to deliver remarkably novel solutions.

Founded in 2021 and initially supported by Vesper Biotechnologies, the Brazilian biotech had already raised R$ 15 million in funding from Arar Capital, Cazanga, Ecoa Capital, MOV Investimentos, and The Yield Lab Latam. The funding allowed Symbiomics to conduct its first proof-of-concept studies, grow its team, open its proprietary laboratory, and build out its development platform for biologicals. “With the Series A, we’ve reached a new stage globally, solidifying Symbiomics as one of the most leading innovators in agribusiness. This growth will increase our capacity to create innovative biological products, reach new partners, and deliver our solutions to farmers,” explains Jader Armanhi, co-founder and COO of Symbiomics.

Symbiomics has established partnerships with several companies in the agricultural sector to co-develop innovative biological solutions. The first products resulting from these collaborations are already in the testing phase, with market launch expected within the next three years.

ABOUT SYMBIOMICS
Symbiomics is a biotechnology company. Founded in 2021, its goal is to globally transform agriculture with next-generation biological products. The company develops high-performance solutions to sustainably increase agricultural productivity, with less environmental impact. The products contain microorganisms used for multiple applications such as plant nutrition, biocontrol, carbon sequestration, and biostimulants. The company’s Research and Development department works with cutting-edge advancements in genomics, microbiomes, and data analysis to enhance agricultural crop productivity through multiple approaches such as biofertilization, increasing resilience to environmental stress, and biological control. More information at: www.symbiomics.com.br and www.linkedin.com/company/symbiomics.

ABOUT CORTEVA AGRISCIENCE
Corteva, Inc. (NYSE: CTVA) is a global pure-play agriculture company that combines industry-leading innovation, high-touch customer engagement and operational execution to profitably deliver solutions for the world’s most pressing agriculture challenges. Corteva generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. With some of the most recognized brands in agriculture and a technology pipeline well positioned to drive growth, the Company is committed to maximizing productivity for farmers, while working with stakeholders throughout the food system as it fulfills its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. More information at: www.corteva.com.

Leave a Reply

Your email address will not be published. Required fields are marked *